Oncopharmpod
Dacomitinib, cemiplimab & #oncopharm updates
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:27:47
- More information
Informações:
Synopsis
Dacomitinib & cemiplimab's respective FDA-approvals are discussed followed by a lightning-round review of 4 immunotherapy studies from the last week. We end with dosing updates for 2 multiple myeloma drugs.
